Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Human-antithrombin-III

 Human antithrombin III

Details
Inventors: Bock, Susan C.; Lawn, Richard M.;
Assignee: Genentech, Inc. (South San Francisco, CA)
Primary Examiner:
Assistant Examiner:
Attorney, Agent or Firm:

A DNA sequence encoding human antithrombin III, cloning vehicles and cells containing that DNA sequence.

DETAILED DESCRIPTION The present invention is directed to the means and methods of producting human antithrombin III via recombinant DNA technology, including (1) the discovery and identity of the entire DNA sequence of the mature protein as well as its signal polypeptide, and the 3'- and 5'-flanking regions thereof; (2) the construction of cloning and expression vehicles comprising said DNA sequence, enabling the amplification, and thence, expression of the mature human antithrombin III protein, as well as Met, fusion, or signal N-terminus conjugates thereof; and (3) viable cell cultures, genetically altered by virtue of their harboring such vehicles and capable of producing human antithrombin III polypeptide.
Further, this invention provides human antithrombin III in physical state distinct from its existence in, or isolation from, a natural environment or source, it by virtue of its method of preparation herein, being essentially free of usual endogenous proteins and other native materials or substances.
This invention is directed to the recombinant DNA production of human antithrombin III in all of its aspects, and is not to be construed as limited to any specific details described herein and embraced within the compass of this invention.
For example, the term "mature" as used herein connotes human ATIII as well as methionyl as a first amino acid, present by virtue of the ATG translational codon in the expression vector construction hereof.
DESCRIPTION OF PREFERRED EMBODIMENTS The work described herein was performed employing, inter alia, the microorganism E.
coli K-12 strain 294 (end A, thi.
sup.
-, hsr.
sup.
-, .
sub.
k hsm.
sup.
+), as described in British Patent Application Publication No.
2055382A.
This strain has been deposited with the American Type Culture Collection, ATCC Accession No.
31446, on Oct.
28, 1978.
However, various other microbial strains are useful, including known E.
coli strains such as E.
coli B, E.
coli .
times.
1776 (ATCC No.
31537, deposited July 3, 1979) and E.
coli W3110 (F



Related patents
  Cryptophycins
OF THE INVENTION The present invention provides novel cryptophycin compounds having the following structure: ##STR4## Wherein R.sub.1 is H, OH, a halogen, O of a ketone ...
  Method for recovery of refined .alpha.-galactosidase
OF THE INVENTION The methods heretofore suggested for the refinement of .alpha.-galactosidase suffer from various disadvantages such as poor recovery ratio, ...
  Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent
The invention provides antimicrobial methods utilizing Type II endoglycosidases such as endo-.beta.-N-acetylglucosaminidase ("Endo") H, D, F and/or PNGase F alone or in ...
  Wound healing composition of IGF-I and TGF-.beta.
We claim: 1. A method for healing an external wound of a mammal comprising applying to said wound a wound-healing amount of a composition consisting essentially or ...
  Flowable demineralized bone powder composition and its use in bone repair
What is claimed is: 1. A flowable composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth-inducing ...
  Crosslinkable polypeptide compositions
OF THE INVENTION In accordance with the present invention, there are provided chemically modified polypeptides having the formula: P--(A--C(O)--Y).sub.n wherein: P is ...

0.044

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved